Inhibikase Therapeutics Inc
NASDAQ:IKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
V
|
Verizon Communications Inc
XBER:BAC
|
US |
|
B
|
Brown & Brown Inc
F:BTW
|
US |
|
A
|
Asahi Group Holdings Ltd
DUS:ABW
|
JP |
|
Novartis AG
SIX:NOVNEE
|
CH |
|
ArcelorMittal SA
OTC:AMSYF
|
LU |
|
A
|
Amgen Inc
XMUN:AMG
|
US |
|
H
|
Hyundai Motor Co
DUS:HYU
|
KR |
|
Vodacom Group Ltd
F:5VD
|
ZA |
Wall St Price Targets
IKT Price Targets Summary
Inhibikase Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
IKT is 6.12 USD with a low forecast of 3.03 USD and a high forecast of 8.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IKT's stock price target?
Price Target
6.12
USD
According to Wall Street analysts, the average 1-year price target for
IKT is 6.12 USD with a low forecast of 3.03 USD and a high forecast of 8.4 USD.